Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
4.520
-0.170 (-3.62%)
At close: Dec 20, 2024, 4:00 PM
4.600
+0.080 (1.77%)
After-hours: Dec 20, 2024, 6:06 PM EST
Nuvectis Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 7.58 | 7.52 | 6.01 | 3.35 | 0.02 |
| Research & Development | 11.69 | 14.38 | 12.03 | 2.45 | - |
| Operating Expenses | 19.26 | 21.9 | 18.03 | 5.79 | 0.02 |
| Operating Income | -19.26 | -21.9 | -18.03 | -5.79 | -0.02 |
| Interest & Investment Income | 0.89 | 0.64 | 0.15 | 0 | - |
| EBT Excluding Unusual Items | -18.37 | -21.26 | -17.89 | -5.79 | -0.02 |
| Other Unusual Items | -1 | -1 | -1.2 | -7.1 | - |
| Pretax Income | -19.37 | -22.26 | -19.09 | -12.89 | -0.02 |
| Net Income | -19.37 | -22.26 | -19.09 | -12.89 | -0.02 |
| Net Income to Common | -19.37 | -22.26 | -19.09 | -12.89 | -0.02 |
| Shares Outstanding (Basic) | 17 | 16 | 13 | 4 | 4 |
| Shares Outstanding (Diluted) | 17 | 16 | 13 | 4 | 4 |
| Shares Change (YoY) | 10.23% | 22.90% | 196.55% | 9.44% | - |
| EPS (Basic) | -1.16 | -1.43 | -1.51 | -3.02 | - |
| EPS (Diluted) | -1.16 | -1.43 | -1.51 | -3.02 | - |
| Free Cash Flow | -13.63 | -15.95 | -13.56 | -9.5 | - |
| Free Cash Flow Per Share | -0.82 | -1.03 | -1.07 | -2.23 | - |
| EBIT | -19.26 | -21.9 | -18.03 | -5.79 | -0.02 |
Source: S&P Capital IQ. Standard template.
Financial Sources.